AVPT vs TECH · P/E 54, rev $330.5M vs P/E 65, rev $1.22B
Avepoint Inc (AVPT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Avepoint Inc (AVPT) is a software - infrastructure company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AVPT revenue for 2024-12-31 was $330.5M. Net income was -$29.1M. Revenue was up 21.6% from 2023-12-31 to 2024-12-31. AVPT currently screens at market cap $2.28B and trailing P/E 53.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AVPT currently screens at market cap $2.28B and trailing P/E 53.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AVPT and TECH stock pages for the full models.
Not investment advice.